"Perform Clinical Trials"

During the past decade, Elite Clinical Studies conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 36 clinical trials were completed, i.e. on average, 73.5% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 29 clinical trials were completed. i.e. 126.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elite Clinical Studies" #1 sponsor was "Shire" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "AOBiome LLC" with 3 trials sponsored, "Amgen" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elite Clinical Studies" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Veristat, Inc." with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Elite Clinical Studies" are "Migraine" (8 trials), "Atherosclerotic Cardiovascular Disease" (3 trials), "Atopic Dermatitis" (3 trials), "Crohn Disease" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Elite Clinical Studies" in a lesser frequency.

Most popular intervention types in "Elite Clinical Studies" are "Drug" (51 trials), "Other" (11 trials), "Biological" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Ontamalimab" (4 trials), "Vehicle" (4 trials), "placebo" (4 trials) and "B244" (3 trials). Other intervention names were less common.

The vast majority of trials in "Elite Clinical Studies" are 59 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Elite Clinical Studies". undefined are not yet recruiting, 13 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Elite Clinical Studies, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Elite Clinical Studies, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".